New EoE Awareness Campaign in New York City’s Times Square

October 27, 2023

New digital advertisements will teach visitors about eosinophilic esophagitis (EoE) and its symptoms

Atlanta, GA – The American Partnership for Eosinophilic Disorders (APFED), a leading advocacy organization for eosinophil-associated disease, is thrilled to announce the launch a fall awareness campaign in Times Square, New York City. This campaign is designed to highlight some of the symptoms of eosinophilic esophagitis (EoE) and prompt the people who recognize symptoms to speak with their doctor.

EoE is a chronic, allergic inflammatory disease of the esophagus (the tube connecting the mouth to the stomach). Symptoms may include, but aren’t limited to difficulty swallowing, reflux, vomiting, and food getting stuck in the throat. Left untreated, EoE may cause narrowing the esophagus and permanent damage.

From October until the end of December, a series of informative advertisements designed to educate the public about EoE symptoms across various age demographics will be featured on a digital billboard located at the northeast corner of the intersection at 1500 Broadway and West 43rd Street.

“Recognizing symptoms that could indicate EoE is crucial for earlier diagnosis and plays a pivotal role in ensuring that patients receive timely treatment,” Mary Jo Strobel, APFED’s Executive Director, shares. “This campaign presents a fantastic chance to engage a wide-ranging audience and provide them with information about the symptoms of EoE and prompt them to seek medical consult if they recognize these symptoms in themselves or their loved ones.”

APFED is grateful to Sanofi and Regeneron for their support of the campaign.

For more information about EoE or other subsets of eosinophil-associated disease, please visit


About the American Partnership for Eosinophilic Disorders (APFED)

The American Partnership for Eosinophilic Disorders (APFED) is a non-profit organization whose mission is to passionately embrace, support, and improve the lives of patients and families affected by eosinophil-associated diseases through education and awareness, research, support, and advocacy.